ORGANIC
LETTERS
2004
Vol. 6, No. 16
2645-2648
Novel Stereoselective Entry to
2′-â-Carbon-Substituted
2′-Deoxy-4′-thionucleosides from
4-Thiofuranoid Glycals
Kazuhiro Haraguchi,* Noriaki Shiina, Yuichi Yoshimura, Hisashi Shimada,
Kyoko Hashimoto, and Hiromichi Tanaka
School of Pharmaceutical Sciences, Showa UniVersity, 1-5-8 Hatanodai,
Shinagawa-ku, Tokyo 142-8555, Japan
Received April 29, 2004
ABSTRACT
2′-â-Methyl- and 2′-â-hydroxymethyl-2′-deoxy-4′-thionucleosides have been synthesized through PhSeCl-mediated electrophilic glycosidation
using 4-thiofuranoid glycals having carbon substituents at the C2-position as a glycosyl donor. Preparation of these glycals were carried out
by means of the C2 lithiation of 1-chloro-4-thiofuranoid glycal with LTMP followed by the Birch reduction of the chlorine atom.
1-â-D-Arabinofuranosylcytosine (ara-C, 1) is an antimetabo-
lite under clinical use for the treatment of leukemia.1 Despite
its effectiveness, it has been pointed out that rapid deami-
nation of 1 leads to inactive 1-â-D-arabinofuranosyluracil.2
To overcome this drawback, a number of 2′-substituted
arabinofuranosyl nucleosides, in which the 2′-hydroxyl group
is replaced with other functional groups, have been evaluated
for their effectiveness as antimetabolites. As a result of these
studies, potent antitumor activity was found in 2′-â-carbon-
substituted analogues such as SMDC (2), SFDC (3), and
CNDAC (4).3
thymidine (5) and 2′-deoxy-4′-thiocytidine (6),4 has stimu-
lated the synthesis of this class of nucleosides, especially
those modified at the sugar moiety. There has been, however,
only one report concerning the synthesis of 2′-â-carbon
substituted 2′-deoxy-4′-thionucleosides.5 As a part of our
ongoing efforts toward the synthesis of 4′-thionucleosides,6
we describe herein a novel stereoselective entry to 2′-â-
carbon substituted analogues using 4-thiofuranoid glycals
having a carbon substituent at the C2 position as a glycosyl
donor.
We previously reported6b that the reaction between 4-thio-
A recent discovery that the simple replacement of the
furanose ring-oxygen of nucleosides with sulfur atom leads
to promising antiviral and antitumor activities, e.g., 4′-thio-
furanoid glycal 7 and silylated nucleobase in the presence
(4) For a review, see: Yokoyama, M. Synthesis 2000, 1637-1655.
(5) 2′-â-Methyl-2′-deoxy-4′-thiouridine and -thymidine have been syn-
thesized by Vorbru¨ggen-type condensation. In this case, due to the steric
hindrance exerted by the 2′-â-methyl substituent, the undesired R-anomers
were obtained as the major products: Uenishi, J. J. Synth. Org. Chem. Jpn.
1997, 55, 186-195.
(6) (a) Haraguchi, K.; Nishikawa, A.; Sasakura, E.; Tanaka, H.; Naka-
mura, K. T.; Miyasaka, T. Tetrahedron Lett. 1998, 39, 3713-3716. (b)
Haraguchi, K.; Takahashi, H.; Shiina, N.; Horii, C.; Yoshimura, Y.;
Nishimura, A.; Sasakura, E.; Nakamura, K. T.; Tanaka, H. J. Org. Chem.
2002, 67, 5919-5927. (c) Haraguchi, K.; Takahashi, H.; Tanaka, H.
Tetrahedron Lett. 2002, 43, 5657-5660.
(1) Keating, M. J.; McCredie, K. B.; Bodey, G. P.; Smith, T. L.; Gehan,
E.; Freidreich, E. J. JAMA 1982, 248, 2481-2486.
(2) (a) Prince, H. N.; Grumgerg, E.; Buck, M.; Cleeland, R. A. Proc.
Soc. Exp. Biol. Med. 1969, 130, 1080-1086. (b) Ho, W. D. H. Cancer.
Res. 1973, 33, 2816-2820. (c) Plunkett, W.; Gandhi, V. Semin. Oncol.
1993, 20, 50-63.
(3) (a) Matsuda, A. In Nucleosides and Nucleotides as Antitumor and
AntiViral Agents; Chu, C. K., Baker, D. C., Eds.; Plenum Press: New York,
1993; pp 1-22. (b) Yoshimura, Y.; Saitoh, K.; Ashida, N.; Sakata, S.;
Matsuda, A. Bioorg. Med. Chem. Lett. 1994, 4, 721-724.
10.1021/ol040035u CCC: $27.50 © 2004 American Chemical Society
Published on Web 07/10/2004